SAWS - ETF AI Analysis
Top Page
AAM Sawgrass US Small Cap Quality Growth ETF (SAWS)
Rating:71Outperform
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, suggesting its strategy has worked well in the recent market environment.
High-Performing Top Holdings
Most of the largest positions, including several health care and technology names, have shown strong year-to-date performance, helping support the fund’s overall returns.
Broad Sector Diversification
The fund spreads its investments across many sectors such as health care, industrials, technology, financials, and consumer stocks, which helps reduce the impact of weakness in any single industry.
Negative Factors
Relatively High Expense Ratio
The ETF charges a moderate-to-high fee for a passive product, which slightly reduces the net return investors keep over time.
Single-Country Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering little geographic diversification if the U.S. market faces a downturn.
Short-Term Performance Weakness
The ETF has shown weak performance over the past month, including at least one top holding that has recently lagged, which may signal near-term volatility.
SAWS vs. SPDR S&P 500 ETF (SPY)
AUM7.92M
RegionNorth America
Expense Ratio0.55%
Beta0.89
IssuerAAM
Inception DateJul 30, 2024
Dividend Yield0.02%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,420
30 Day Avg. Volume1,475
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
28.69Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering73
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SAWS Summary
SAWS is the AAM Sawgrass US Small Cap Quality Growth ETF, focused on smaller U.S. companies that are aiming to grow quickly. It doesn’t track a traditional index, but instead selects “quality” small-cap growth stocks across areas like health care, industrials, and technology. Examples of companies it holds include StoneX Group and PriceSmart. An investor might consider SAWS to add growth potential and diversification beyond large, well-known stocks. However, because it invests in smaller companies, the share price can be more volatile and may go up and down more sharply than the overall market.
How much will it cost me?The AAM Sawgrass US Small Cap Quality Growth ETF (Ticker: SAWS) has an expense ratio of 0.55%, meaning you’ll pay $5.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on selecting high-quality small-cap growth stocks rather than tracking a broad index.
What would affect this ETF?The SAWS ETF, focused on U.S. small-cap growth companies, could benefit from a strong U.S. economy, technological innovation, and increased demand for healthcare and industrial solutions, given its sector exposure. However, it may face challenges from rising interest rates, which can make borrowing more expensive for small companies, and economic slowdowns that could disproportionately impact smaller firms. Regulatory changes or sector-specific disruptions in industries like technology or healthcare could also influence its performance.
SAWS Top 10 Holdings
SAWS leans into U.S. small-cap growth with a mix of niche industrials, health care, and tech names quietly steering returns. BrightSpring Health Services and A10 Networks have been rising, giving the fund some welcome lift from health care and cybersecurity themes. Gorman-Rupp and Pricesmart add steady, if less flashy, support from industrials and consumer names. On the flip side, StoneX Group and Archrock have been lagging lately, acting as mild brakes. Overall, the ETF is diversified across sectors but still firmly rooted in U.S. small-cap growth stories.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| StoneX Group | 4.15% | $324.47K | $9.10B | 74.52% | 58 Neutral | |
| Pricesmart | 3.34% | $261.00K | $5.98B | 77.79% | 77 Outperform | |
| BrightSpring Health Services, Inc. | 3.20% | $250.18K | $11.72B | 212.32% | 67 Neutral | |
| Iradimed | 2.90% | $226.88K | $1.16B | 29.52% | 78 Outperform | |
| Archrock | 2.88% | $225.50K | $6.27B | 53.97% | 79 Outperform | |
| Guardian Pharmacy Services, Inc. Class A | 2.84% | $222.24K | $2.50B | 101.43% | 54 Neutral | |
| Gorman-Rupp Company | 2.62% | $205.17K | $2.14B | 97.71% | 76 Outperform | |
| Enova International | 2.49% | $194.93K | $6.33B | 152.02% | 71 Outperform | |
| Digi International | 2.47% | $192.85K | $2.63B | 122.08% | 77 Outperform | |
| Mueller Industries | 2.39% | $187.14K | $14.69B | 56.42% | 78 Outperform |
SAWS Technical Analysis
Positive
―
Price Trends
24.57
Positive
23.56
Positive
22.57
Positive
Market Momentum
>-0.01
Negative
56.11
Neutral
76.40
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SAWS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 24.68, equal to the 50-day MA of 24.57, and equal to the 200-day MA of 22.57, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 56.11 is Neutral, neither overbought nor oversold. The STOCH value of 76.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SAWS.
SAWS Peer Comparison
Comparison Results
Performance Comparison
SAWS
AAM Sawgrass US Small Cap Quality Growth ETF
25.08
5.52
28.22%
TMFS
Motley Fool Small-Cap Growth ETF
―
―
―
MMSC
First Trust Multi-Manager Small Cap Opportunities ETF
―
―
―
SGRW
Harbor Active Small Cap Growth ETF
―
―
―
ACSG
American Century Small Cap Growth Insights ETF
―
―
―
FSEG
Fidelity Enhanced Small Cap Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents